Trial Profile
A Real-world, observational study to evaluate the risk of Acute kidney injury associated with Sofosbuvir-containing regimens in hepatitis C virus patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 02 Feb 2017 New trial record